drugset / Trial / NCT00000605

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

NCT00000605 ↗

RandomizedDouble-blindPrevention

Summary

To determine if postmenopausal hormone replacement therapy in women following coronary bypass surgery would reduce the occurrence of graft occlusion and delay the development of graft atherosclerosis.

Timeline

Start
1996-08
Primary completion
—
Completion
2002-07

Drugs

EvaluationDrugModalityDoseRoute
Subject conjugated estrogen Unknown — —
Subject medroxyprogesterone acetate Other / unclassified — —